In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – BRCA2, but not BRCA1, gene mutation is associated with improved survival and response to chemotherapy in women with high-grade serous ovarian cancer, an…
NEW YORK (Reuters Health) – Patients with congenital bladder anomalies managed by enterocystoplasty do not need to undergo annual urine cytology and endoscopy, Rochester, Minnesota-based researchers report in…
NEW YORK (Reuters Health) – Managing food allergy in infants, children and adolescents is nothing short of challenging, for a whole host of reasons. A State-of-the-Art Review Article…
NEW YORK (Reuters Health) – Even patients with severe migraine and tension-type headache may find relief with an over-the-counter analgesic that combines aspirin, acetaminophen and caffeine, according to…
NEW YORK (Reuters Health) – Insulin sensitizers may reduce the accelerated loss in muscle mass and strength seen in elderly men with type 2 diabetes, according to a…
NEW YORK (Reuters Health) – Cardiac allografts might function better when brain-dead organ donors are treated with low-dose dopamine, researchers report. They say the approach — already known…
NEW YORK (Reuters Health) – A specially convened work group has concluded that routine screening of newborns for critical congenital heart disease, based on the detection of low…
NEW YORK (Reuters Health) – A single pediatric dose of adjuvanted vaccine against pandemic influenza A/H1N1 (pH1N1) is better than 80% effective at 10 days after administration for…
NEW YORK (Reuters Health) – Contrary to expectations, dietary supplementation with omega-3 (n-3) fatty acids and antioxidants does not improve outcomes in patients with acute lung injury. In…
NEW YORK (Reuters Health) – In advanced renal cell cancer, targeted inhibitors of the vascular epithelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pathways improve progression-free…
